SunLink Health Systems
About: SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
Employees: 1,851
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
2.8% less ownership
Funds ownership: 14.12% [Q4 2024] → 11.32% (-2.8%) [Q1 2025]
6% less funds holding
Funds holding: 17 [Q4 2024] → 16 (-1) [Q1 2025]
9% less capital invested
Capital invested by funds: $874K [Q4 2024] → $797K (-$77.2K) [Q1 2025]
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Research analyst outlook
We haven’t received any recent analyst ratings for SSY.
Financial journalist opinion
Neutral
Business Wire
1 month ago
SunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $630,000 (or a loss of $0.09 per fully diluted share) for its third fiscal quarter ended March 31, 2025 compared to a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for the third fiscal quarter ended March 31, 2025. Net loss for the quarter ended March 31, 2025 was $671,000 (or a loss of $0.10 per fully diluted share) compared.
Neutral
Business Wire
4 months ago
SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results.
Neutral
Business Wire
5 months ago
SUNLINK HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SunLink Health Systems, Inc. - SSY
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of SunLink Health Systems, Inc. (NYSE: SSY) and Regional Health Properties, Inc. (NYSE: RHE). Pursuant to the terms of the agreement, at the closing of the transaction, SunLink shareholders will own approximately 43.0% of the combined company. KSF is seeking to determine whether the merger and the process that.
Neutral
Business Wire
5 months ago
SSY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of SunLink Health Systems, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of SunLink Health Systems, Inc. (NYSE American: SSY) and Regional Health Properties, Inc. is fair to SunLink shareholders. Upon completion of the proposed transaction, SunLink shareholders will own approximately 43.0% of the combined company. Halper Sadeh encourages SunLink shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary H.
Neutral
Business Wire
5 months ago
Shareholder Alert: Ademi LLP Investigates Whether SunLink Health Systems, Inc. Is Obtaining a Fair Price for Its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating SunLink (NYSE American: SSY) for possible breaches of fiduciary duty and other violations of law in its transaction with the Regional Health Properties. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, SunLink shareholders will receive an aggregate of 1,410,000 shares of Regional comm.
Neutral
Business Wire
7 months ago
SunLink Health Systems, Inc. Announces Fiscal 2025 First Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2024 compared to a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for the first fiscal quarter ended September 30, 2023. During the quarter ended September 30, 2024, the Company sold non-core assets for cash totaling $1,465,0.
Neutral
Business Wire
8 months ago
SunLink Health Systems, Inc. Announces Sale of Trace Regional Hospital Real Estate
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., and an affiliate, have completed the sale of the hospital building and related real estate of its formerly operated Trace Regional Hospital in Houston, Mississippi for approximately $2,000,000. The company said the net proceeds of approximately $1,932,000 will be retained for working capital and general corporate purposes. The company exp.
Neutral
Business Wire
8 months ago
SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth fiscal quarter ended June 30, 2024 compared to a loss from continuing operations of $1,021,000 (or a loss of $0.15 per fully diluted share) for the fourth fiscal quarter ended June 30, 2023. Earnings from discontinued operations were $4,940,000 (or earnings of $0.70 per fully diluted share) for the f.
Neutral
Business Wire
1 year ago
SunLink Health Systems, Inc. Announces Sale of Trace Extended Care & Rehab
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Extended Care & Rehab senior care facility and related real estate in Houston, Mississippi for approximately $7,100,000. The company said the net proceeds of approximately $6,500,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax gain.
Neutral
Business Wire
1 year ago
SunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for its third fiscal quarter ended March 31, 2024 compared to a loss from continuing operations of $453,000 (or a loss of $0.06 per fully diluted share) for the third fiscal quarter ended March 31, 2023. Net loss for the quarter ended March 31, 2024 was $1,396,000 (or a loss of $0.20 per fully diluted share) compar.
Charts implemented using Lightweight Charts™